戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ty, LV assist device implantation, or heart transplantation was assessed.
2 ive accuracy of a previously validated polygenic risk score was assessed among 4847 adults of white European ancestry, ag
3 nternational Prostate Symptom Score (IPSS); sexual function was assessed by 5-item version of the International Index of
4                                                    Accuracy was assessed by analysis of SRM (Standard Reference Material)
5 nducing cardiomyopathy, and cardiac function and remodeling was assessed by echocardiography 10 weeks after surgery.
6  of regional genes and a retinal enhancer RNA at this locus was assessed by qPCR.
7                                            Urinary function was assessed by residual urine volume, maximal flow rate (MFR
8 mittee on Cancer (AJCC) tumor stage at each criterion level was assessed by using Cohen kappa statistics.
9 een May 19 and October 27, 2016, a systematic random sample was assessed for eligibility (HIV+, age >= 14 years, on ART >
10                                                  The cohort was assessed for subsequent future fragility fractures.
11 d RBC-MVs to activate each zymogen of the intrinsic pathway was assessed in a buffer system.
12                                                      Safety was assessed in all participants who received at least one do
13                                                      Safety was assessed in all patients who received at least one dose o
14 lipid peroxidation) on mitochondrial function and structure was assessed in HL1 murine cardiomyocytes and human induced p
15 sess which memories predicted drinking, real-world behavior was assessed in patients with AUD at baseline and for 4 weeks
16                                        The primary endpoint was assessed in the intention-to-treat analysis set, after al
17                                          Dementia incidence was assessed over 3-5 years, with diagnosis according to the
18                    Based on the RCSQ results, sleep quality was assessed to be better in the melatonin group than that in
19                                                      Safety was assessed up to 48 h post-injection.
20                                      Impact of additive EBL was assessed using 20 3-factor fistula risk score (FRS) scena
21 -inferiority of DTG + FTC versus cART for viral suppression was assessed using a stratified Mantel-Haenszel risk differen
22                                   The breast tissue density was assessed using ACR BI-RADS.
23  of the amygdala, fornix, uncinate fasciculus, and cingulum was assessed using fractional anisotropy and mean diffusivity
24                                           Surface stability was assessed using infectivity, SARS-CoV-2 survived on stainl
25 he gradual alteration of mortality risk after ICU admission was assessed using left-truncation with increasing minimum su
26 rsion 5, and its relationship with parenchyma-absorbed dose was assessed using linear models.
27 lationship between mean and sectoral variation of ACA width was assessed using locally-weighted scatterplot smoothing (LO
28                                                   Mediation was assessed using structural equation modeling.
29                                     Post-operative survival was assessed using time-dependent Cox proportional hazard reg
30                                     Quantification accuracy was assessed with Dice scores, group comparisons and correlat
31 ient survival, and predictors of graft and patient survival were assessed.
32             Adverse events and pharmacokinetic measurements were assessed.
33 d miRNAs, cel-miR-71-5p and bma-lin-4, and O-150 repeat DNA were assessed.
34                                                    Outcomes were assessed according to patients' receipt of initial asses
35 ir therapeutic efficacy and preliminary toxicology profiles were assessed and compared in vivo in an adjuvant-induced art
36                                      Intakes of free sugars were assessed at 1 and 2 y of age.
37                                      Mortality and mobility were assessed at 30 and 60 d after surgery.
38                       1554 patients with mild-to-severe TBI were assessed at 6 months post injury on the Glasgow Outcome
39                                          Gait and cognition were assessed at the year 30 examination.
40                                        Twenty-seven studies were assessed by bivariate meta-analysis.
41  (63 +/- 11 years of age, 53% were male) with suspected CAD were assessed by stress CMR and followed over a median of 5.4
42 s coefficient (K(app)) between malignant and benign lesions were assessed by using a logistic mixed model.
43                                                      Images were assessed for the presence of RMA.
44                                           Leukocyte subsets were assessed in nasal mucosa biopsies at baseline and after
45                                Predictors of HH improvement were assessed in this multivariate model.
46                                                Six patients were assessed once.
47                                           Clinical symptoms were assessed retrospectively and compared with age- and sex-
48 a a novel spray-drying powdering process without additives, were assessed to characterise their sugar and phenolic profil
49 acteristics and self-reported acute and persistent symptoms were assessed using a standardized detailed questionnaire adm
50                          In vivo BP and regional blood flow were assessed using Doppler flow and telemetry in young (14-1